Philips Expands its Cybersecurity Services Portfolio for Healthcare Providers

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its medical device cybersecurity services portfolio at HIMSS22. Philips is introducing Secure Remote Access Management Service [1], leveraging the broad set of security capabilities enabled by the integration of SecureLink's critical access management and governance technology with Philips Remote Services' secure connectivity framework for technical and clinical support. The services provide benefits for healthcare providers including increased uptime, clinical performance, and advanced security to help protect access to their clinical solutions and medical devices.

"We are continuously expanding the foundation of Philips Cybersecurity Services and this type of integration is a strong complement to our offering, giving our customers more options for building robust cybersecurity programs," said Gal Gnainsky, Head of Security at Philips. "As healthcare providers’ cybersecurity requirements continue to increase, partnering with SecureLink highlights Philips' focus on offering best-in-class solutions to provide more secure access management and protect health networks down to granular device level."

Philips Remote Services: a key enabler of digital transformation in healthcare

Remote services have become an essential component of the digital transformation of healthcare. Philips’ portfolio of remote services is utilized to monitor key performance parameters for many clinical systems and devices on a continuous basis and alert customers of potential issues and rectify them, often remotely, before they result in system or device failures that interrupt patient care. During the COVID-19 pandemic, they played an important role in helping to keep hospitals operational at a time when on-site maintenance was logistically difficult. Applying artificial intelligence (AI) and predictive analytics to the acquired data, they are also important to support the goals of zero system downtime, increased efficiency, and seamless uninterrupted workflows.

Secure access to combat increasing cyber threats in healthcare

By integrating with SecureLink's vendor privileged access management and governance capabilities, the Philips Remote Services portfolio now provides additional capabilities, offering a uniform level of security, visibility, traceability, and audit capability needed for critical access management and data security. SecureLink's solutions allow customers to manage privileged access sessions with rich audit logging, limiting access to relevant devices and systems and granting only 'need to know' permissions required to monitor or maintain them.

"SecureLink is the industry leader in critical access management, empowering organizations to secure access to their most valuable assets, including networks, systems, and data. By partnering with Philips we are extending the web of security offered by our critical access management technology across their customer base and the healthcare ecosystem at large," said Joel Burleson Davis, Chief Technology Officer of SecureLink. "With cybercrime in healthcare at an all-time high [2], partnerships like that between SecureLink and Philips are essential to protecting healthcare systems, data and patients from today's increasingly sophisticated cyber threats."

Security by design

The Philips Cybersecurity Services portfolio comprises an end-to-end suite of technologies and services to safeguard customers' medical systems, devices, and related software regardless of vendor, helping empower the digital transformation in healthcare. The company’s approach to cybersecurity is characterized by end-to-end 'Security by Design' principles that focus on security during product design, development, testing, and deployment right through to in-use performance monitoring, system updates, and incident response management. Philips also contributes to the development of national and international cybersecurity standards for medical devices, and its Cybersecurity Services portfolio aligns with global cybersecurity best practices and standards. The Philips Remote Services operating environment implements security controls that meet the internationally recognized ISO/IEC 27001 Information Security Management Systems standard.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries.

1. Philips Secure Remote Access Management Service will be available for selected Philips Remote Service enabled systems in the USA and Canada from Q3 2022. Philips will continue to expand Secure Remote Access Management Service to support more systems and remote service solutions.
2 https://cybersecurity.criticalinsight.com/2021_H2_HealthcareDataBreachReport

Most Popular Now

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

ChatGPT Performs as Well as Doctors for …

The artificial intelligence chatbot ChatGPT performed as well as a trained doctor in suggesting likely diagnoses for patients being assessed in emergency medicine departments, in a pilot study to be...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...

AI may Outperform Most Humans at Creativ…

Large language model (LLM) artificial intelligence (AI) chatbots may be able to outperform the average human at a creative thinking task where the participant devises alternative uses for everyday objects...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

AI and Machine Learning can Successfully…

Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common hormone disorder among women, typically between ages 15 and...